Regulatory T cells in autoimmune neuroinflammation

被引:229
作者
Kleinewietfeld, Markus [1 ,2 ,3 ,4 ]
Hafler, David A. [1 ,2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA USA
[4] Dresden Univ Technol TUD, Fac Med, Dresden, Germany
基金
美国国家卫生研究院;
关键词
autoimmunity; Treg; multiple sclerosis; FoxP3; regulatory T cells; Tr1; MULTIPLE-SCLEROSIS PATIENTS; HUMAN DENDRITIC CELLS; FOXP3; EXPRESSION; TREG CELLS; TH17; CELLS; IN-VITRO; TRANSCRIPTION FACTOR; VITAMIN-D; EX-VIVO; INDOLEAMINE 2,3-DIOXYGENASE;
D O I
10.1111/imr.12169
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Regulatory T cells are the central element for the maintenance of peripheral tolerance. Several subtypes of regulatory T (Treg) cells have been described, and most of them belong to the CD4(+) T-helper (Th) cell lineage. These specific subtypes can be discriminated according to phenotype and function. Forkhead box protein 3 (FoxP3)-expressing natural Treg cells (Tregs) and IL-10-producing, T-regulatory type 1 cells (Tr1) are the best-studied types of CD4(+) regulatory T cells in humans and experimental animal models. It was shown that they play a crucial role during autoimmune neuroinflammation. Both cells types seem to be particularly important for multiple sclerosis (MS). Here, we discuss the role of CD4(+) regulatory T cells in autoimmune neuroinflammation with an emphasis on Tregs and Tr1 cells in MS.
引用
收藏
页码:231 / 244
页数:14
相关论文
共 168 条
[1]
Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases [J].
Adorini, L .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (07) :1017-1028
[2]
Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3 [J].
Allan, Sarah E. ;
Alstad, Alicia N. ;
Merindol, Natacha ;
Crellin, Natasha K. ;
Amendola, Mario ;
Bacchetta, Rosa ;
Naldini, Luigi ;
Roncarolo, Maria Grazia ;
Soudeyns, Hugo ;
Levings, Megan K. .
MOLECULAR THERAPY, 2008, 16 (01) :194-202
[3]
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production [J].
Allan, Sarah E. ;
Crome, Sarah Q. ;
Crellin, Natasha K. ;
Passerini, Laura ;
Steiner, Theodore S. ;
Bacchetta, Rosa ;
Roncarolo, Maria G. ;
Levings, Megan K. .
INTERNATIONAL IMMUNOLOGY, 2007, 19 (04) :345-354
[4]
Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3 [J].
Allan, Sarah E. ;
Song-Zhao, George X. ;
Abraham, Thomas ;
McMurchy, Alicia N. ;
Levings, Megan K. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (12) :3282-3289
[5]
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27 [J].
Apetoh, Lionel ;
Quintana, Francisco J. ;
Pot, Caroline ;
Joller, Nicole ;
Xiao, Sheng ;
Kumar, Deepak ;
Burns, Evan J. ;
Sherr, David H. ;
Weiner, Howard L. ;
Kuchroo, Vijay K. .
NATURE IMMUNOLOGY, 2010, 11 (09) :854-U112
[6]
In vivo instruction of suppressor commitment in naive T cells [J].
Apostolou, I ;
von Boehmer, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408
[7]
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors [J].
Ascherio, Alberto ;
Munger, Kassandra L. .
ANNALS OF NEUROLOGY, 2007, 61 (06) :504-513
[8]
The initiation and prevention of multiple sclerosis [J].
Ascherio, Alberto ;
Munger, Kassandra L. ;
Luenemann, Jan D. .
NATURE REVIEWS NEUROLOGY, 2012, 8 (11) :602-612
[9]
CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation [J].
Astier, A ;
Trescol-Biémont, MC ;
Azocar, O ;
Lamouille, B ;
Rabourdin-Combe, C .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6091-6095
[10]
Abnormal Tr1 differentiation in multiple sclerosis [J].
Astier, Ame L. ;
Hafler, David A. .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 191 (1-2) :70-78